What is Supernus Pharmaceuticals's investment purchases?

Supernus Pharmaceuticals (SUPN) reported investment purchases of $78.44M in Q1 2026.

How has Supernus Pharmaceuticals's investment purchases changed year-over-year?

Supernus Pharmaceuticals's investment purchases decreased by 33.8% year-over-year, from $118.56M to $78.44M.

What is the long-term trend for Supernus Pharmaceuticals's investment purchases?

Over 3 years (2022 to 2025), Supernus Pharmaceuticals's investment purchases has grown at a 5.4% compound annual growth rate (CAGR), from $406.99M to $475.94M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

Supernus Pharmaceuticals SUPN Investment Purchases

Investment Purchases at other companies

Rapport Therapeutics, Inc.RAPP

$30.37M-29.8%

Neurocrine BiosciencesNBIX

$819.5M+200%

Jazz PharmaceuticalsJAZZ

$500M+13.6%

Acadia PharmaceuticalsACAD

$15.01M-90.4%

Praxis Precision Medicines, Inc.PRAX

$486.78M+316%

Harmony Biosciences Holdings, Inc.HRMY

$179M+836%

Other financials

Income statement

See full

Revenue$207.7M+38.6%

Gross profit$184.3M+37.5%

Operating income-$8.3M+18.8%

Net income-$2.3M+80.6%

EPS (diluted)-$0.04+81.0%

Balance sheet

See full

Cash & equivalents$186.3M+60.8%

Total debt$40.9M+26.6%

Total equity$1.1B+4.5%

Total assets$1.5B+11.4%

Cash flow

See full

Operating cash flow$66.5M+117%

CapEx--100%

Free cash flow$66.5M+120%

Valuation

See full

Market cap$2.58B+62.8%

Enterprise value$2.44B+62.3%

P/S3.3×+0.9×

Profitability

See full

Gross margin89.4%+1.0pp

Operating margin-7.8%-18.9pp

Net margin-3.7%-13.0pp

FCF margin27.9%+3.4pp

Returns & leverage

See full

Return on equity-2.8%-9.1pp

Debt / equity0×0.0×

Current ratio2×-0.5×

Where this comes from

Reported directly by Supernus Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Supernus Pharmaceuticals's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Supernus Pharmaceuticals's investment purchases?: Supernus Pharmaceuticals (SUPN) reported investment purchases of $78.44M in Q1 2026.
How has Supernus Pharmaceuticals's investment purchases changed year-over-year?: Supernus Pharmaceuticals's investment purchases decreased by 33.8% year-over-year, from $118.56M to $78.44M.
What is the long-term trend for Supernus Pharmaceuticals's investment purchases?: Over 3 years (2022 to 2025), Supernus Pharmaceuticals's investment purchases has grown at a 5.4% compound annual growth rate (CAGR), from $406.99M to $475.94M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.